efficacy and long-term follow-up of il-1r inhibitor anakinra in adults with stills disease a case-series study疗效和长期随访的il-1r抑制剂anakinra成年人仍然病病例分析研究.pdfVIP

  • 1
  • 0
  • 约5.9万字
  • 约 9页
  • 2017-09-06 发布于上海
  • 举报

efficacy and long-term follow-up of il-1r inhibitor anakinra in adults with stills disease a case-series study疗效和长期随访的il-1r抑制剂anakinra成年人仍然病病例分析研究.pdf

efficacy and long-term follow-up of il-1r inhibitor anakinra in adults with stills disease a case-series study疗效和长期随访的il-1r抑制剂anakinra成年人仍然病病例分析研究

Laskari et al. Arthritis Research Therapy 2011, 13:R91 /content/13/3/R91 RESEARCH ARTICLE Open Access Efficacy and long-term follow-up of IL-1R inhibitor anakinra in adults with Still’s disease: a case-series study * Katerina Laskari , Athanasios G Tzioufas and Haralampos M Moutsopoulos Abstract Introduction: To assess the efficacy and safety of the interleukin-1 receptor (IL-1R) inhibitor anakinra in adult patients with refractory Still’s disease. Met

您可能关注的文档

文档评论(0)

1亿VIP精品文档

相关文档